The subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.source https://timesofindia.indiatimes.com/india/govt-panel-to-review-eua-application-for-generic-covid-19-pill/articleshow/87766153.cms
Comments
Post a Comment